Synapsoft logo
AI Insights from Disclosures
Searching...
HLB PHARMACEUTICAL CO., LTD. 047920
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
HLB PHARMACEUTICAL CO., LTD. was established in 1998 as Citri Co., Ltd., and changed to its current name in October 2020 when it joined the HLB Group. The company's core businesses are the manufacture and sale of prescription drugs, contract manufacturing (CMO) services, and the sale of health functional food, and it conducts R&D on new drugs and improved new drugs based on long-acting injectable formulations (DDS, Drug Delivery System), centered on its Dongtan Research Institute.
Representative Director Park Jaehyeong
Founded April 23, 1998
Corporation Type KOSDAQ
Industry Classification Research and experimental development on physics, chemistry and biology
Corporate number 11011-1538391
Business number 208-81-25623
Phone Number 02-411-1514
Fax Number 02-411-1590
Company Address 27 Gyeonggang-ro, Namyangju-si, Gyeonggi-do
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant